II
RPRX icon

Inspire Investing’s Royalty Pharma RPRX Stock Holding History

Inspire Investing’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.47M Buy
79,780
+46,034
+136% +$2.4M 0.18% 112
2026
Q1 		$1.62M Sell
33,746
-7,424
-18% -$325K 0.09% 261
2025
Q4 		$1.59M Buy
41,170
+2,618
+7% +$99.8K 0.14% 162
2025
Q3 		$1.36M Buy
38,552
+6,195
+19% +$224K 0.13% 175
2025
Q2 		$1.17M Buy
32,357
+22,436
+226% +$743K 0.13% 181
2025
Q1 		$309K Sell
9,921
-241
-2% -$7.64K 0.04% 781
2024
Q4 		$259K Buy
10,162
+91
+0.9% +$2.41K 0.03% 777
2024
Q3 		$285K Buy
10,071
+85
+0.9% +$2.35K 0.03% 795
2024
Q2 		$263K Sell
9,986
-33,538
-77% -$930K 0.03% 777
2024
Q1 		$1.32M Buy
43,524
+27,701
+175% +$817K 0.14% 180
2023
Q4 		$444K Buy
15,823
+2,410
+18% +$66.2K 0.05% 329
2023
Q3 		$364K Buy
+13,413
New +$398K 0.05% 344
2023
Q2 		– Sell
-14,699
Closed -$530K – 825
2023
Q1 		$530K Buy
+14,699
New +$545K 0.07% 224

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Inspire Investing's RPRX Position: Q2 2026 in Review

Inspire Investing increased its Royalty Pharma (RPRX) stake by 136% in Q2 2026, buying an estimated $2.4M and bringing the position to 79,780 shares worth $4.47M. The position accounts for 0.18% of the portfolio, ranked #112.

Inspire Investing first reported a position in RPRX in Q1 2023 and has held it in 13 quarters since. 643 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • Inspire Investing held 79,780 shares of Royalty Pharma worth $4.47M as of Q2 2026.
  • Inspire Investing bought 46,034 Royalty Pharma shares in Q2 2026, an estimated $2.4M.
  • Royalty Pharma made up 0.18% of Inspire Investing's portfolio in Q2 2026, its #112 holding.
  • Inspire Investing first reported a position in Royalty Pharma in Q1 2023 and has held it in 13 quarters since.
  • 643 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Inspire Investing's 13F filing for Q2 2026, filed 12 Aug 2026.